Cardinal Health and Vineti announce collaboration to deliver integrated commercial and logistics solutions to cell and gene therapy manufacturers
by Vineti | May 20, 2020
Cardinal Health and Vineti Inc. announced a collaboration to support cell and gene therapy manufacturers with a fully integrated solution that aligns logistics and commercialization services with digital Chain of Identity and Chain of Custody…
by Amy DuRoss | May 5, 2020
Today, Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, is very pleased to share the news of new appointments for Heidi Hagen, Co-founder and Advisor, Louise Pacini, Chief Strategy Officer, and Brett…
by Vineti | April 14, 2020
Vineti turned 4 on April 10th.
by Heidi Hagen and Christophe Suchet | April 2, 2020
The COVID-19 pandemic presents all of us with a dynamic, disruptive challenge unlike anything most of us have experienced in our lifetime. As we publish this post, we very much hope that all of you are safe and healthy.
Quality Management Systems for advanced therapies, Part 5: what does a successful QMS look like in advanced therapies?
by Heidi Hagen and Subbu Viswanathan | March 18, 2020
This post is the final post in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management) for personalized therapies, such as cell therapies, gene therapies, or neoantigen cancer vaccines. This series focuses…